161 related articles for article (PubMed ID: 38098959)
1. Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm.
Shah AM; Pereira D; Poveda J; Wang TP
Leuk Res Rep; 2023; 20():100380. PubMed ID: 38098959
[TBL] [Abstract][Full Text] [Related]
2. Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.
Abla D; Abboud MR; Noun D; Tarek N; Pemmaraju N
Leuk Res Rep; 2022; 17():100313. PubMed ID: 35462725
[TBL] [Abstract][Full Text] [Related]
3. Blastic Plasmacytoid Dendritic Cell Neoplasm in Long-Term Complete Remission After Venetoclax Monotherapy.
Sasaki Y; Murai S; Shiozawa E; Yamochi T; Hattori N
Cureus; 2024 Jan; 16(1):e52446. PubMed ID: 38371152
[TBL] [Abstract][Full Text] [Related]
4. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
Albiol N; Novelli S; Mozos A; Pratcorona M; Martino R; Sierra J
J Med Case Rep; 2021 Jun; 15(1):326. PubMed ID: 34172079
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy Combined with Venetoclax Followed by Allo-Hematopoietic Stem Cell Transplantation for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang LL; Wang QX; Guan J; Zhou Y; Hu B; Feng Y; Zou L; Cheng H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1531-1536. PubMed ID: 37846712
[TBL] [Abstract][Full Text] [Related]
6. Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review.
Wang Q; Zhao Y; Zang X; Zhou G; Liu Y; Feng Q; Li X; Wang W; Dong X; Liu X; Peng J; Liu C
Ann Hematol; 2024 Mar; 103(3):999-1005. PubMed ID: 38285081
[TBL] [Abstract][Full Text] [Related]
7. Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm.
Nagate Y; Nakaya A; Kamimura R; Hirose Y; Nojima S; Fujita J; Kiyohara E; Shibayama H
Intern Med; 2023; 62(17):2547-2551. PubMed ID: 37661416
[TBL] [Abstract][Full Text] [Related]
8. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
[TBL] [Abstract][Full Text] [Related]
9. Blastic Plasmacytoid Dendritic Cell Neoplasm With Central Nervous System Involvement: A Case Report.
Molina Castro D; Perilla Suárez O; Cuervo-Sierra J; Moreno A
Cureus; 2022 Apr; 14(4):e23888. PubMed ID: 35530883
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
[TBL] [Abstract][Full Text] [Related]
11. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jain A; Sweet K
J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
[TBL] [Abstract][Full Text] [Related]
12. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case.
Al-Alwan A; Khalid F; Vyas C; Sirpal V; Bader H
J Community Hosp Intern Med Perspect; 2023; 13(4):79-81. PubMed ID: 37868236
[TBL] [Abstract][Full Text] [Related]
13. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.
Montero J; Stephansky J; Cai T; Griffin GK; Cabal-Hierro L; Togami K; Hogdal LJ; Galinsky I; Morgan EA; Aster JC; Davids MS; LeBoeuf NR; Stone RM; Konopleva M; Pemmaraju N; Letai A; Lane AA
Cancer Discov; 2017 Feb; 7(2):156-164. PubMed ID: 27986708
[TBL] [Abstract][Full Text] [Related]
14. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.
Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE
Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581
[TBL] [Abstract][Full Text] [Related]
15. Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation.
Jiang YL; Li Q; Yuan T; Jiang YY; Deng Q
Onco Targets Ther; 2020; 13():3425-3430. PubMed ID: 32368098
[TBL] [Abstract][Full Text] [Related]
16. Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy.
Narli Ozdemir Z; Cengiz Seval G; Sahin U; Uslu A; Gunduz M; Civriz Bozdag S; Toprak SK; Kurt Yuksel M; Topcuoglu P; Kuzu I; Ozcan M; Gurman G; Ilhan O
Indian J Hematol Blood Transfus; 2021 Jan; 37(1):67-75. PubMed ID: 33707837
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kharfan-Dabaja MA; Cherry M
Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
Kharfan-Dabaja MA; Al Malki MM; Deotare U; Raj RV; El-Jurdi N; Majhail N; Cherry MA; Bashir Q; Darrah J; Nishihori T; Sibai H; Hamadani M; de Lima M; Gerds AT; Selby G; Qazilbash MH; Forman SJ; Ayala E; Lipton JH; Hari PN; Muzzafar T; Zhang L; Olteanu H; Perkins J; Sokol L; Kumar A; Ahmed S
Br J Haematol; 2017 Dec; 179(5):781-789. PubMed ID: 28980314
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies.
Kharfan-Dabaja MA; Pemmaraju N; Mohty M
Clin Hematol Int; 2019 Mar; 1(1):2-9. PubMed ID: 34595405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
